[Show abstract] [Hide abstract]
ABSTRACT: N-Phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (9) and related piperidine acetamide derivatives have good oral activity in the elevated plus maze, an animal model predictive of clinical efficacy for the treatment of anxiety. Modest affinity was observed for the neurokinin NK-1 and 2 receptors, which are known to be involved in the regulation of mood and emotion.
Bioorganic & Medicinal Chemistry Letters 07/2006; 16(11):3065-7. · 2.34 Impact Factor